J&J exhibited additional findings from the Vivacity-MG3 study, displaying that nipocalimab met its key secondary endpoint.

Tourmaline Bio's Pacibekitug shows promise in IL-6 targeting for autoimmune diseases. Learn about its potential and ongoing trials. Read why TRML is a hold.

Researchers explore how natural compounds in traditional Chinese medicine can modulate cholesterol metabolism to combat cancer.

Chen says. However, the diterpene compounds seem to impact how much LDL receptors in cells are able to process circulating LDL in the body, he says. Diterpenes also seem to suppress enzymes linked ...

CRANBURY, N.J., March 25, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality worldwide. Cardiovascular (CV) risk reduction is important in patients at high risk for a first ...

Reagents: FA (Solarbio, Cat.F8330); Dimethyl Sulfoxide (DMSO) (Solarbio, Cat.D8370); ox-LDL (Yiyuan, Cat.YB-002-1); Fetal Bovine Serum (Biosharp ... and vascular endothelial growth factor receptor-1 ...

A: My default approach for frontline treatment is a doublet therapy, which includes ADT with a luteinizing hormone–releasing hormone [LHRH] agonist or antagonist, such as leuprolide [Lupron], along ...

State Key Laboratory of Metabolism and Regulation in Complex Organisms, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life ...